Pharmachoi

Pharmachoi

资深美股专家,关注美股biotech pipeline,clinical and regulatory events.

他的全部讨论

讨论

$Trident(TDAC)$ $LTRY,下周一见

讨论

$PAVmed(PAVM)$ 再跌的话要忍不住加了哈

讨论

$Trident(TDAC)$ 慢慢等待起飞,今年5倍。

讨论

$Affimed(AFMD)$ 还是很便宜

讨论

$Affimed(AFMD)$ 4名患者2cr,2pr。

讨论

$Affimed(AFMD)$ first Patient Successfully Dosed in First-in-Human Phase 1/2A Study of AFM24 for the Treatment of Advanced EGFR-Expressing Solid Tumors Including Colon, Lung and Other Cancers

讨论

$Marker Therapeutics(MRKR)$ DJ FDA Authorizes Blood-Purification Device for Coronavirus Patients
By Dave Sebastian
The U.S. Food and Drug Administration said it has issued an emergency-use authorization for a blood-purification system to treat Covid-19 patients who ha...

讨论

$Pluristem疗法(PSTI)$ Seven ICU-housed patients with acute respiratory distress syndrome were treated under a compassionate use program. Six completed the seven-day follow-up period (the seventh is still within the period).
All survived. Three are in advanced stages of we...

讨论

$Affimed(AFMD)$ 2020年4月2日–致力于让患者恢复其与生俱来的抗癌能力的临床阶段免疫肿瘤公司(纳斯达克:AFMD)今天提供了其应对COVID-19冠状病毒大流行持续蔓延的最新运营情况。阿菲迈德还宣布,将于2020年4月28日(星期二)美国东部时间上午8:30召开电话会议,讨论其2019年全年的财务业绩和最近的...

讨论

$Myovant Sciences(MYOV)$ Myovant Sciences Ltd $MYOV Major Shareholder Chemical Co. Ltd. Sumitomo Purchases 140,000 Shares

讨论

$Affimed(AFMD)$ $afmd expect preliminary AFM13 data in PTCL at 2020 year-end, with more visibility on an accelerated regulatory path. Initial AFM24 data in EGFR+ solid tumors is expected in late 2020 and could provide additional upside.

讨论

$Dicerna制药(DRNA)$
迪克纳提供来自菲奥克斯的初步观察™奈达西仑治疗原发性高草酸尿症的3项试验及数据展示计划的更新
—初步中期数据显示四名患者的第一个亚组中草酸盐水平正常化或接近正常化—
—将在草酸欧洲会议上展示的多剂量数据现已改期至2020年6月16日——
东部夏令时20...

讨论

$Affimed(AFMD)$ SUMMARY:
- AFM13 FDA granted Orphan Drug Designation and activated 39 clinical studies sites
- AFM24 Phase 1/2a started
- Genentech collaboration progressing and unimpacted by the COVID-19